Skip to main content
. Author manuscript; available in PMC: 2022 Jun 10.
Published in final edited form as: J Palliat Med. 2021 Jul 13;25(1):46–53. doi: 10.1089/jpm.2021.0199

Table 2.

Multivariable Models of Lung Re-Expansion and Mortality after Palliative Radiotherapy for Pulmonary Obstruction

Re-expansion a
Overall mortality b
Hazard ratio 95% confidence interval p Hazard ratio 95% confidence interval p

Age 0.99 0.96–1.02 0.60 1.00 0.98–1.03 0.77
Histology (vs. NSCLC)
 SCLC 0.83 0.21–3.23 0.78 1.06 0.50–2.25 0.88
 Metastasis 0.89 0.31–2.57 0.84 0.34 0.14–0.82 0.02
ECOG 3–4 (vs. 1–2) 0.71 0.30–1.70 0.44 2.70 1.57–4.66 <0.01
Extent of obstruction (entire lung vs. lobar) 1.76 0.50–6.12 0.38 0.89 0.43–1.84 0.75
Tumor size <6 cm (vs. ≥6 cm) 2.16 0.92–5.09 0.08 0.53 0.29–0.95 0.03
Inpatient (vs. outpatient) 0.44 0.17–1.12 0.08 1.74 0.94–3.20 0.08
Obstruction 30+ days (vs. <30 days) 0.58 0.24–1.41 0.23 0.51 0.29–0.93 0.03
No. of fractions (vs. 1)
 2–5 2.31 0.54–9.96 0.26 0.34 0.15–0.77 0.01
 10 2.41 0.69–8.36 0.17 0.24 0.11–0.50 <0.01
Re-expansion 0.28 0.15–0.52 <0.01
a

Competing risk regression.

b

Cox proportional hazards.